The 20 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 110.50, with a high estimate of 127.00 and a low estimate of 97.00. The median estimate represents a +8.12% increase from the last price of 102.20.
The current consensus among 23 polled investment analysts is to Buy stock in Abbvie Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.86
Reporting Date Jan 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.